Literature DB >> 34030585

Moxetumomab pasudotox as re-treatment for heavily-pretreated relapsed hairy cell leukemia.

Ilana R Yurkiewicz1, Steve Coutre1, Herve Ghesquieres2, Ira Pastan3, Robert J Kreitman3.   

Abstract

Entities:  

Year:  2021        PMID： 34030585     DOI： 10.1080/10428194.2021.1929959

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical study.

Authors:  Guannan Wang; Alok Kumar; Wanjun Ding; Preethi Korangath; Tapan Bera; Junxia Wei; Priya Pai; Kathleen Gabrielson; Ira Pastan; Saraswati Sukumar
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-08       Impact factor: 12.779
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.